{"transactions":[{"id":4629158,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-10-02T21:19:22.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":4.511,"value":135330.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.440 to $4.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1328130,"source":{"system":"sec-edgar","filing":"0001213900-26-106530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026106530/ownership.xml","form_type":"4"}},{"id":4626994,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2026-09-25T20:31:13.000Z","date":"2026-09-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 24, 2026, the issuer canceled all outstanding stock options held by the reporting person pursuant to an option exchange program approved by the Compensation Committee of the issuer's Board of Directors. In exchange for the canceled options, the reporting person received a restricted stock award of an aggregate of 75,455 shares, which fully vested upon grant, valued at $4.75 per share (the closing price on September 22, 2026), equal to the aggregate Black-Scholes value of the canceled options. The option cancellation and restricted stock grant were each approved in advance by a committee of non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The canceled option provided for vesting in 4 equal installments as follows: 9,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-26-103538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026103538/ownership.xml","form_type":"4"}},{"id":4626993,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2026-09-25T20:31:13.000Z","date":"2026-09-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 24, 2026, the issuer canceled all outstanding stock options held by the reporting person pursuant to an option exchange program approved by the Compensation Committee of the issuer's Board of Directors. In exchange for the canceled options, the reporting person received a restricted stock award of an aggregate of 75,455 shares, which fully vested upon grant, valued at $4.75 per share (the closing price on September 22, 2026), equal to the aggregate Black-Scholes value of the canceled options. The option cancellation and restricted stock grant were each approved in advance by a committee of non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The canceled option provided for vesting in 4 equal installments as follows: 12,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":10.4,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-26-103538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026103538/ownership.xml","form_type":"4"}},{"id":4626992,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2026-09-25T20:31:13.000Z","date":"2026-09-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 24, 2026, the issuer canceled all outstanding stock options held by the reporting person pursuant to an option exchange program approved by the Compensation Committee of the issuer's Board of Directors. In exchange for the canceled options, the reporting person received a restricted stock award of an aggregate of 75,455 shares, which fully vested upon grant, valued at $4.75 per share (the closing price on September 22, 2026), equal to the aggregate Black-Scholes value of the canceled options. The option cancellation and restricted stock grant were each approved in advance by a committee of non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The canceled option provided for vesting in 16 equal installments of 6,250 on the first day of every three-month period beginning November 1, 2019. Of the vested options, 50,000 were previously exercised."}],"balance_after":0,"derivative":{"exercise_price":3.69,"expiration_date":"2029-09-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-26-103538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026103538/ownership.xml","form_type":"4"}},{"id":4626991,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-09-25T20:31:13.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":209291,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 24, 2026, the issuer granted to the reporting person a restricted stock award of an aggregate of 209,291 shares pursuant to the issuer's Amended and Restated 2019 Stock Incentive Plan (the \"Plan\"). The restricted stock vests as to forty percent (40%) on the date of grant and as to the remaining sixty percent (60%) in eight (8) substantially equal quarterly installments over the twenty-four (24) month period following the date of grant, subject to the reporting person's continued service with the issuer. Unvested shares are subject to forfeiture in accordance with the terms of the applicable award agreement and the Plan."}],"balance_after":1358130,"source":{"system":"sec-edgar","filing":"0001213900-26-103538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026103538/ownership.xml","form_type":"4"}},{"id":4626990,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-09-25T20:31:13.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":75455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 24, 2026, the issuer canceled all outstanding stock options held by the reporting person pursuant to an option exchange program approved by the Compensation Committee of the issuer's Board of Directors. In exchange for the canceled options, the reporting person received a restricted stock award of an aggregate of 75,455 shares, which fully vested upon grant, valued at $4.75 per share (the closing price on September 22, 2026), equal to the aggregate Black-Scholes value of the canceled options. The option cancellation and restricted stock grant were each approved in advance by a committee of non-employee directors."}],"balance_after":1148839,"source":{"system":"sec-edgar","filing":"0001213900-26-103538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573235/000121390026103538/ownership.xml","form_type":"4"}},{"id":718773,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2026-07-02T21:00:11.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vested and became exercisable in 16 equal installments of 6,250 on the first day of every three-month period beginning November 1, 2019."}],"balance_after":50000,"derivative":{"exercise_price":3.69,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-26-075070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026075070/ownership.xml","form_type":"4"}},{"id":718772,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-07-02T21:00:11.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.69,"value":184500.0,"ownership":{"direct":true},"balance_after":1073384,"source":{"system":"sec-edgar","filing":"0001213900-26-075070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026075070/ownership.xml","form_type":"4"}},{"id":718771,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-07-02T21:00:11.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":137000,"price":4.463,"value":611431.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.255 to $4.7652, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1023384,"source":{"system":"sec-edgar","filing":"0001213900-26-075070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026075070/ownership.xml","form_type":"4"}},{"id":835480,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-03-18T21:46:15.000Z","date":"2026-03-17","kind":"grant","planned":false,"acquired":true,"shares":95889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer."}],"balance_after":1160384,"source":{"system":"sec-edgar","filing":"0001213900-26-031012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026031012/ownership.xml","form_type":"4"}},{"id":928072,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Performance Stock Units","published_at":"2026-01-29T21:05:35.000Z","date":"2026-01-22","kind":"exercise","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share (\"Common Stock\"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represented a contingent right to receive one share of the Issuer's Common Stock upon achievement of the applicable performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU represented a contingent right to receive one share of the Issuer's Common Stock upon achievement of the applicable performance criteria."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001213900-26-009477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026009477/ownership.xml","form_type":"4"}},{"id":928071,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-01-29T21:05:35.000Z","date":"2026-01-22","kind":"exercise","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share (\"Common Stock\"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the vesting of performance stock units (\"PSUs\") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share (\"Common Stock\"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting."}],"balance_after":1064495,"source":{"system":"sec-edgar","filing":"0001213900-26-009477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026009477/ownership.xml","form_type":"4"}},{"id":952495,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Performance Stock Units","published_at":"2026-01-05T22:20:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria."}],"balance_after":19000,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001213900-26-001278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001278/ownership.xml","form_type":"4"}},{"id":952494,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-01-05T22:20:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."}],"balance_after":1045495,"source":{"system":"sec-edgar","filing":"0001213900-26-001278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001278/ownership.xml","form_type":"4"}},{"id":952493,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-01-05T22:20:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":97328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."}],"balance_after":930495,"source":{"system":"sec-edgar","filing":"0001213900-26-001278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001278/ownership.xml","form_type":"4"}},{"id":1274393,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-11T21:31:21.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria."}],"balance_after":833167,"source":{"system":"sec-edgar","filing":"0001213900-25-012240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025012240/ownership.xml","form_type":"4"}},{"id":1274392,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-11T21:31:21.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria."}],"balance_after":799833,"source":{"system":"sec-edgar","filing":"0001213900-25-012240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025012240/ownership.xml","form_type":"4"}},{"id":1274391,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-11T21:31:21.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued on settlement of performance stock units (\"PSUs\") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria."}],"balance_after":751333,"source":{"system":"sec-edgar","filing":"0001213900-25-012240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025012240/ownership.xml","form_type":"4"}},{"id":1311338,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-01-06T21:10:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":194500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in quarterly installments of approximately 16,208 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":706333,"source":{"system":"sec-edgar","filing":"0001213900-25-001165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025001165/ownership.xml","form_type":"4"}},{"id":1371696,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-11-08T21:30:22.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":511833,"source":{"system":"sec-edgar","filing":"0001213900-24-095929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024095929/ownership.xml","form_type":"4"}},{"id":1684521,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-01-08T21:40:12.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":180500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in quarterly installments of approximately 15,042 over a three year period starting January 8,\n2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":481833,"source":{"system":"sec-edgar","filing":"0001209191-24-001148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001148/doc4.xml","form_type":"4"}},{"id":1873525,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2023-05-31T21:10:13.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":27000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis."}],"balance_after":301333,"source":{"system":"sec-edgar","filing":"0001209191-23-033142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123033142/doc4.xml","form_type":"4"}},{"id":1916600,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2023-04-20T10:00:27.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":108000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal quarterly installments of 9,000 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":274333,"source":{"system":"sec-edgar","filing":"0001209191-23-024940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123024940/doc4.xml","form_type":"4"}},{"id":2199215,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-08-02T00:00:47.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":42000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 14,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":166333,"source":{"system":"sec-edgar","filing":"0001209191-22-043767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122043767/doc4.xml","form_type":"4"}},{"id":2444631,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:33:48.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in 4 installments as follows: 9,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":36000,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-22-000807","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000807/ownership.xml","form_type":"4"}},{"id":2444630,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-01-06T01:33:48.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 5,250 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":124333,"source":{"system":"sec-edgar","filing":"0001213900-22-000807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000807/ownership.xml","form_type":"4"}},{"id":2582053,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating & BO"}}],"security":"Common Stock","published_at":"2021-09-02T20:46:07.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis."}],"balance_after":103333,"source":{"system":"sec-edgar","filing":"0001213900-21-046410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021046410/ownership.xml","form_type":"4"}},{"id":2874787,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-08T22:29:57.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Stock Option will vest in 4 equal installments as follows: 12,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 4 equal installments as follows: 12,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024."}],"balance_after":50000,"derivative":{"exercise_price":10.4,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-21-007497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021007497/ownership.xml","form_type":"4"}},{"id":3414025,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf. Op. & Bus. Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-09-16T22:04:50.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options will vest in 16 equal installments of 6,250 on the first day of every three month period beginning November 1, 2019."}],"balance_after":100000,"derivative":{"exercise_price":3.69,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-19-018196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019018196/ownership.xml","form_type":"4"}},{"id":3944401,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-05-07T20:51:04.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 16 equal installments of 1,875 on the last day of each quarter commencing June 30, 2018."}],"balance_after":30000,"derivative":{"exercise_price":6.7,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-18-005618","document":"f4050318hexter_oramedpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390018005618/f4050318hexter_oramedpharm.xml","form_type":"4"}},{"id":3966242,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-04-10T21:41:55.000Z","date":"2018-04-08","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 4 equal installments of 7,500 on each of April 1, 2019, April 1, 2020, April 1, 2021 and April 1, 2022."}],"balance_after":30000,"derivative":{"exercise_price":7.05,"expiration_date":"2028-04-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-18-004250","document":"f4040818hexter_oramedpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390018004250/f4040818hexter_oramedpharm.xml","form_type":"4"}},{"id":4545276,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":17853,"kind":"person","name":"Hexter Joshua","position":1,"cik":"0001573235","reported_name":"Hexter Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-11-22T20:35:00.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: 9,000 shares vest immediately; 1,500 shares will vest in 18 consecutive installments on the last day of each month commencing November 30, 2016; and 17,000 will vest in each of April 30, 2017 and April 30, 2018."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001213900-16-018868","document":"f4110116hexter_oramedpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390016018868/f4110116hexter_oramedpharma.xml","form_type":"4"}}]}